Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, epirubicin, cyclophosphamide,
and doxorubicin, work in different ways to stop tumor cells from dividing so they stop
growing or die. It is not yet known which combination chemotherapy regimen is more effective
in treating breast cancer.
PURPOSE: This randomized phase III trial is studying two combination chemotherapy regimens to
compare how well they work in treating women who have undergone surgery for breast cancer
that has not spread to the lymph nodes.